Comparison of platelet hemostasis effects for angiotensin receptor blockers in patients with arterial hypertension and metabolic syndrome

The authors compared platelet hemostasis effects for two angiotensin receptor blockers, valsartan and eprosartan, in patients with arterial hypertension (AH) and metabolic syndrome (MS). For 16 weeks, 34 patients received valsartan, and 32 - eprosartan. Plasma and platelet lipid peroxidation product...

Full description

Saved in:

Bibliographic Details
Published in:	Rossiĭskiĭ kardiologicheskiĭ zhurnal no. 4; pp. 52 - 56
Main Authors:	I. N. Medvedev, T. A. Kumova
Format:	Journal Article
Language:	Russian
Published:	FIRMA «SILICEA» LLC 01-08-2007
Subjects:	arterial hypertension eprosartan metabolic syndrome platelets valsartan
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The authors compared platelet hemostasis effects for two angiotensin receptor blockers, valsartan and eprosartan, in patients with arterial hypertension (AH) and metabolic syndrome (MS). For 16 weeks, 34 patients received valsartan, and 32 - eprosartan. Plasma and platelet lipid peroxidation products, blood and platelet antioxidant potential, platelet hemostasis parameters were investigated. Data were analyzed using Student t statistics. Valsartan therapy in AH and MS patients reduced peroxidation syndrome and optimized primary hemostasis. To reduce body weight in such patients, valsartan should be combined with non-pharmaceutical methods.
ISSN:	1560-4071 2618-7620